Riskpilot← Back to searchSign inGet full accessMERCK LIFE SCIENCE A/S
A/SDissolvedCVR 73131510Vandtårnsvej 62A, 5. aWholesale of pharmaceutical and medical goods · NACE 4646Est. 19828 employees
Revenue 2018
DKK 16,1M
-37% vs 2017
EBITDA margin
48.7%
-53% vs 2017
Equity ratio
71.2%
Financial strength
Net profit 2018
DKK 4,8M
-55% vs 2017
| Revenue | DKK 16,1M | -37% |
| EBITDA | DKK 7,9M | -53% |
| Net profit | DKK 4,8M | -55% |
| Total assets | DKK 60,8M | -10% |
| Equity | DKK 43,2M | +12% |
| Employees | 8 | — |
Legal name
MERCK LIFE SCIENCE A/S
CVR number
73131510
Legal form
Aktieselskab
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
31. december 1982
Share capital
DKK 2.000.000
Employees
8 (FTE)
VAT registered
No
Audit selected
No
Last report
2018-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af et medlem af bestyrelsen alene eller af en direktør alene
Address
Vandtårnsvej 62A, 5. a
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2014 | 2015 | 2016 | 2017 | 2018 |
|---|---|---|---|---|---|
| Revenue | 10.213 | 14.263 | 18.994 | 25.589 | 16.137 |
| Staff expenses | -6.902 | -8.306 | -7.670 | -8.811 | -8.279 |
| EBITDA | 3.311 | 5.957 | 11.324 | 16.778 | 7.858 |
| Depreciation & amort. | -0 | -1.564 | -1.564 | -1.563 | -1.564 |
| EBIT | 3.311 | 4.393 | 9.760 | 15.215 | 6.294 |
| Net financials | -21 | -437 | -249 | -717 | -143 |
| Profit before tax | 3.290 | 3.956 | 9.511 | 14.498 | 6.151 |
| Tax | 1.179 | 643 | 1.575 | 3.755 | 1.360 |
| Net profit | 2.111 | 3.313 | 7.936 | 10.743 | 4.791 |
| Item | 2014 | 2015 | 2016 | 2017 | 2018 |
|---|---|---|---|---|---|
| Total assets | 27.445 | 59.239 | 40.901 | 67.147 | 60.750 |
| Equity | 16.458 | 19.771 | 27.707 | 38.450 | 43.241 |
| Long-term debt | 12 | 97 | 96 | 26 | 65 |
| Short-term debt | 10.987 | 39.371 | 13.098 | 28.251 | 17.444 |
| Total debt | 10.987 | 39.468 | 13.194 | 28.277 | 17.509 |
EBITDA margin
48.7%
This company
15.8%
Market median
+208% vs market
20142018
Equity ratio
71.2%
This company
38.2%
Market median
+86% vs market
20142018
Return on equity
11.1%
This company
18.4%
Market median
+40% vs market
20142018
Net profit margin
29.7%
This company
8.1%
Market median
+267% vs market
20142018
Asset turnover
0.27×
This company
1.12×
Market median
-76% vs market
20142018
Debt / equity
0.40×
This company
0.62×
Market median
+35% vs market
20142018
- Annual report 2018Filed via CVR / Virk · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via CVR / Virk · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via CVR / Virk · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via CVR / Virk · Period 2015-01-01 – 2015-12-31
- Annual report 2014Filed via CVR / Virk · Period 2014-01-01 – 2014-12-31
| Name | Role | Member since |
|---|---|---|
| Former (8) | ||
CS Management | Management | 2005 – 2008 |
BB Management | Management | 1982 – 2001 |
PA Management | Management | 2001 – 2005 |
BP Management | Management | 1982 – 1994 |
DC Management | Management | 2008 – 2012 |
EÁ Chief Executive Officer | Chief Executive Officer | 2019 – 2019 |
HC Chief Executive Officer | Chief Executive Officer | 2012 – 2018 |
TM Chief Executive Officer | Chief Executive Officer | 2018 – 2019 |
| Name | Role | Member since |
|---|---|---|
| Former (12) | ||
| Board of Directors | 1982 – 2001 | |
| Chairman | 2012 – 2014 | |
| Board of Directors | 2003 – 2005 | |
| Board of Directors | 1982 – 1998 | |
| Board of Directors | 1982 – 2008 | |
| Board of Directors | 2014 – 2015 | |
| Board of Directors | 2005 – 2008 | |
| Board of Directors | 2018 – 2019 | |
| Chairman | 2019 – 2019 | |
| Board of Directors | 2008 – 2012 | |
| Board of Directors | 2008 – 2012 | |
| Board of Directors | 2001 – 2003 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Individual | 100% | 100% | 1982 | |
| Individual | 100% | 100% | 2016 | |
| Individual | 100% | 100% | 2016 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of MERCK LIFE SCIENCE A/S also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Claude Sturni | Management | 0 companies |
| Benny Bjerregaard | Management | 0 companies |
| Pirjo Anneli Lehvänen | Management | 0 companies |
| Benny Post | Management | 0 companies |
| Didier Charles Kauffer | Management | 0 companies |
| Enrique Álvarez Fernández | Chief Executive Officer | 0 companies |
| Hans Christopher Elers Koch | Chief Executive Officer | 0 companies |
| Tiina Marjatta Puhakka | Chief Executive Officer | 0 companies |
| Gianpiero Orlandi | Board of Directors | 0 companies |
| Péter Bíró | Chairman | 0 companies |
| John Edward Lary | Board of Directors | 0 companies |
| Geoffrey Nunes | Board of Directors | 0 companies |
| Jeffrey Rudin | Board of Directors | 0 companies |
| Sven Håkan Englund | Board of Directors | 0 companies |
| Kathleen Beaumont Allen | Board of Directors | 0 companies |
| Renée Christine Tunold | Board of Directors | 0 companies |
| Jeanette Sandholmen | Chairman | 0 companies |
| Anthony Laurence Mattacchione | Board of Directors | 0 companies |
| Daniel Abram Milewich | Board of Directors | 0 companies |
| John Docksey Steven | Board of Directors | 0 companies |